Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Apply for scholarships through the CAIA Foundation

Thursday, March 03, 2011
Opalesque Industry Update - A new way to build knowledge and talent in alternative investments: Introducing the CAIA Foundation.

The CAIA Association reached another milestone with the creation of the new CAIA Foundation. As a charitable organization, the CAIA Foundation will enable individuals, organizations, and businesses in the finance industry to invest in building the knowledge and talent in the field of alternative investments.

The CAIA Foundation’s first offering, the 100 Women in Hedge Funds/CAIA Scholars program, is now accepting applications. The scholarship package includes enrollment and registration fees for CAIA Level I and Level II exams, the CAIA Knowledge Series textbooks, the Schweser CAIA Level 1 Premium Plus Program Support, and the first year CAIA Association membership fee. The first 10 scholarship recipients will sit for the September 2011 CAIA Level I exam.

The sponsors of the 100 Women in Hedge Funds/CAIA Scholarship are:

  • 100 Women in Hedge Funds, a non-profit organization for professionals in the alternatives industry
  • Pacific Alternative Asset Management Company LLC, an independent fund of hedge funds investment firm
  • Kaplan Schweser, a leading global provider of financial and accounting educational solutions
  • Wiley, publisher of the CAIA Knowledge Series textbooks

The deadline to apply for the scholarship is Friday, April 15. Learn more about eligibility requirements and apply...Corporate website: Source
PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for